The neurologist’s dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately

Abstract

Get full access to this article

View all access options for this article.

References

Vercellino

Plano

Votta

. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 1101–1107.

Kutzelnigg

Lucchinetti

Stadelmann

. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705–2712.

Peterson

Mork

. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389–400.

Fisher

Lee

Nakamura

. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008; 64: 255–265.

Henderson

Barnett

Parratt

. Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Ann Neurol 2009; 66: 739–753.

Nikic

Merkler

Sorbara

. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 2011; 17: 495–499.

Geurts

Pouwels

. Cortical lesions in multiple sclerosis: Combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26: 572–577.

Geurts

Pouwels

Uitdehaag

. Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236: 254–260.

Seewann

Kooi

Roosendaal

. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology. 2012 Jan 31; 78(5): 302–8. Epub 2012 Jan 4. MID:22218278

10.

Fisniku

Chard

Jackson

. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64: 247–254.

11.

Calabrese

Rinaldi

Mattisi

. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology 2010; 74: 321–328.

The neurologist’s dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately – Yes

Abstract

Get full access to this article

References